OOIR: Observatory of International Research

Papers

(The median citation count of International Journal of Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
[Corrigendum] Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3‑kinase inhibitor (ZSTK474)	182
Anti‑angiogenic effect of Bryopsis plumosa‑derived peptide via aquaporin 3 in non‑small cell lung cancer	132
[Retracted] Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway	117
Identification and characterization of slow‑cycling cells in Ewing sarcoma	76
[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways	69
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m⁶₂A and CD) regulations on patients with cancer and healthy individuals	60
Histone lysine demethylase 3B regulates autophagy via transcriptional regulation of GABARAPL1 in acute myeloid leukemia cells	58
Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer	58
snoRNAs and their derived sdRNAs: Emerging regulators, biomarkers, and therapeutic targets in human cancers (Review)	57
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review)	52
From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review)	49
Unraveling the roles of fibroblast activation protein‑positive cancer‑associated fibroblasts in cancer: From mechanisms to therapy (Review)	44
TGF‑β1 in cancer: From tumour suppressor to promoter, molecular mechanisms, and precision therapeutic strategies (Review)	42
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes	41
Role of miR‑181a‑5p in cancer (Review)	39
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)	38
[Retracted] Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis	34
Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment response	33
[Retracted] Feroniellin A‑induced autophagy causes apoptosis in multidrug‑resistant human A549 lung cancer cells	33
GSTO1 confers drug resistance in HCT‑116 colon cancer cells through an interaction with TNFαIP3/A20	32
[Retracted] MicroRNA‑155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2	32
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors	30
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer	29
[Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression	29
Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review)	29

[Retracted] Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma	29
RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review)	28
Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells	28
Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigenin	28
Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)	27
Targeting the cuproptosis‑associated gene COL22A1 in glioblastoma using EMD‑1204831 and kaempferol	27
Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review)	26
Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma	26
Understanding the epigenetic regulation of lactylation and aberrant lactate metabolism in cancer: From mechanisms to therapeutic strategies (Review)	26
[Corrigendum] Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression	24
[Corrigendum] (‑)‑Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase‑dependent pathway and Bcl‑2 family protein modulation	24
Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review)	24
[Corrigendum] HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3	24
Current updates on the structural and functional aspects of the CRISPR/Cas13 system for RNA targeting and editing: A next‑generation tool for cancer management (Review)	24
Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6‑methyladenosine‑mediated post‑transcriptional regulation	23
Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)	23
Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer	23
Application of cfDNA methylation in cancer prognostic assessment: Progress and challenges (Review)	23
Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway	23
Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review)	23
VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization	23
AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer	23
[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway	22
Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review)	22
[Expression of Concern] Establishment and evaluation of a new highly metastatic tumor cell line 5a‑D‑Luc‑ZsGreen expressing both luciferase and green fluorescent protein	22
Role of miRNA‑122 in cancer (Review)	21
[Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells	21
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)	21
lncRNA AL445238.2‑USP4 axis regulates cell survival and stemness in colon cancer	21
Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)	20
An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review)	20
[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4	20
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer	20
A multi‑omics study of diagnostic markers and the unique inflammatory tumor micro‑environment involved in tuberous sclerosis complex‑related renal angiomyolipoma	20
[Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule‑targeting agent docetaxel in breast cancer	20
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)	20
[Retracted] MicroRNA‑181a regulates epithelial‑mesenchymal transition by targeting PTEN in drug‑resistant lung adenocarcinoma cells	20
Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review)	19
[Expression of Concern] MicroRNA‑195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways	19
Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway	19
The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells	19
[Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway	19
Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL3	19
Role of DCLK1 in oncogenic signaling (Review)	19
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway	19
[Corrigendum] Podoplanin‑mediated TGF‑β‑induced epithelial‑mesen‑ chymal transition and its correlation with bHLH transcription factor DEC in TE‑11 cells	19
[Retracted] NR4A1‑induced increase in the sensitivity of a human gastric cancer line to TNFα‑mediated apoptosis is associated with the inhibition of JNK/Parkin‑dependent mitophagy	19
Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review)	19
Significance of signal recognition particle 9 nuclear translocation: Implications for pancreatic cancer prognosis and functionality	18
LGR4 promotes proliferation and homing via activation of the NF‑κB signaling pathway in multiple myeloma	18

CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review)	18
Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells	18
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)	18
[Corrigendum] Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma	18
Ferroptosis in biliary tract cancer: Molecular mechanisms and therapeutic applications (Review)	18
miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α	17
RPL9 acts as an oncogene by shuttling miRNAs through exosomes in human hepatocellular carcinoma cells	17
Exosome as a crucial communicator between tumor microenvironment and gastric cancer (Review)	17
[Retracted] Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion	17
Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9	17
Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review)	16
Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer	16
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review)	16
Radiotherapy resistance in glioblastoma: Mechanistic insights and novel therapeutic approaches (Review)	16
Targeted therapy in BRAF‑mutant melanoma: Advances and challenges (Review)	16
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer	16
Therapeutic potentials of plant‑based antioxidants on colorectal cancer: Challenges and perspectives (Review)	16
Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review)	16
MicroRNA in adenoid cystic carcinoma (Review)	16
[Corrigendum] The role of IGFBP‑5 in mediating the anti‑proliferation effect of tetrandrine in human colon cancer cells	16
[Retracted] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration	15
[Corrigendum] Leptin promotes breast cancer cell migration and invasion via IL‑18 expression and secretion	15
Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome	15
Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review)	15
Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia	15
[Expression of Concern] Regulation of NADPH oxidase (Nox2) by lipid rafts in breast carcinoma cells	15
[Retracted] Slug contributes to cancer progression by direct regulation of ERα signaling pathway	14
[Corrigendum] Wnt‑signaling and apoptosis after neoadjuvant short‑term radiotherapy for rectal cancer	14
P2X7 receptor: An emerging therapeutic target in acute myeloid leukemia	14
[Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis	14
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)	14
[Retracted] lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma	14
Roles of salt‑inducible kinases in cancer (Review)	14
[Expression of Concern] Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase‑9	13
Targeting drug resistance in glioblastoma (Review)	13
T‑box transcription factor 15 regulated by methyltransferase‑like 3‑mediated N6‑methyladenosine modification promotes immune escape and progression of gastric cancer by activating matrix metalloprotei	13
Antimicrobial agent chloroxylenol targets β‑catenin‑mediated Wnt signaling and exerts anticancer activity in colorectal cancer	13
m⁶A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling	13
[Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma	13
Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer	13
Tumour follower cells: A novel driver of leader cells in collective invasion (Review)	13
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells	13
[Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells	13
Research advances in aptamers in the diagnosis and treatment of breast cancer (Review)	13
[Retracted] Expression and function of PIM kinases in osteosarcoma	13
Protein lactylation and immunotherapy in gliomas: A novel regulatory axis in tumor metabolism (Review)	13
[Retracted] Glycyrrhetinic acid induces G1‑phase cell cycle arrest in human non‑small cell lung cancer cells through endoplasmic reticulum stress pathway	13
Circular RNAs in osteosarcoma: An update of recent studies (Review)	13
[Corrigendum] The mechanism of adenosine‑mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells	13
RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling	13
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance	12
USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation	12
Function of microRNA‑124 in the pathogenesis of cancer (Review)	12
Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma	12
Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation	12
ZBTB20 promotes ferroptosis through inhibiting TMEM109 expression in glioblastoma cells	12
New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review)	12
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)	12
Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia	12
IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review)	12
Galectin‑1 binds GRP78 to promote the proliferation and metastasis of gastric cancer	11
[Corrigendum] STAT3 activation in HER2‑overexpressing breast cancer promotes epithelial‑mesenchymal transition and cancer stem cell traits	11
Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1/ACSL4 pathway	11
mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review)	11
[Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion	11
[Retracted] Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF‑7 breast cancer cells	11
[Retracted] Downregulation of uPA/uPAR inhibits intermittent hypoxia‑induced epithelial‑mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells	11
Gefitinib enhances the anti‑tumor immune response against EGFR‑mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H	11
Role of microRNAs in glycolysis in gynecological tumors (Review)	11
[Retracted] Matrix metalloproteinase‑1 promotes prostate tumor growth and metastasis	11
Smoking promotes colorectal cancer via the CKAP2L/AREG axis	11
Metabolic remodeling by circular RNAs in gastric tumorigenesis: From mechanisms to biomarker discovery (Review)	11
[Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation	10
[Retracted] MicroRNA‑511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway	10
Role of exosomal non‑coding RNAs in cancer‑associated fibroblast‑mediated therapy resistance (Review)	10
Exosomal integrins in tumor progression, treatment and clinical prediction (Review)	10
Extracellular vesicle‑mediated miR‑126‑3p transfer contributes to inter‑cellular communication in the liver tumor microenvironment	10
[Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHR	10
Activation of DDX58/RIG‑I suppresses the growth of tumor cells by inhibiting STAT3/CSE signaling in colon cancer	10
Impact of PD‑L1 upregulation on immune checkpoint inhibitor efficacy in triple‑negative breast cancer using a 4T1 murine model	10

P2Y₂R‑mediated transactivation of VEGFR2 through Src phosphorylation is associated with ESM‑1 overexpression in radiotherapy‑resistant‑triple negative breast cancer cells	10
Cancer‑associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review)	10
Role and research progress of spasmolytic polypeptide‑expressing metaplasia in gastric cancer (Review)	10
KMO downregulation promotes hepatocellular carcinoma growth via 3‑HAA‑mediated mitochondrial mass and function imbalances	10
New insights into lipid metabolism and prostate cancer (Review)	10
The apelin‑apelin receptor signaling pathway in fibroblasts is involved in tumor growth via p53 expression of cancer cells	9
[Corrigendum] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion	9
Dual inhibition of EGFR‑VEGF: An effective approach to the treatment of advanced non‑small cell lung cancer with EGFR mutation (Review)	9
Altered expression of the IGF2‑H19 locus and mitochondrial respiratory complexes in adrenocortical carcinoma	9
Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway	9
[Retracted] Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase‑2	9
[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles	9
Advances in the study of the breast carcinoma exosomal microRNAs: from basic mechanisms to clinical applications (Review)	9
Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicine	9
Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway	9
[Retracted] SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non‑small cell lung cancer cells through deacetylation of NMNAT2	9
Hyperthermia reduces cancer cell invasion and combats chemoresistance and immune evasion in human bladder cancer	9
Mechanisms of chemoresistance in diffuse large B‑cell lymphoma and novel therapeutic strategies (Review)	9
SUCLG1 promotes aerobic respiration and progression in plexiform neurofibroma	9
[Corrigendum] The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells	9
Role of N⁶‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)	9
Role of metabolic reprogramming of cancer‑associated fibroblasts in tumor development and progression (Review)	8
Diverse roles of SERPINE1 in regulating cellular proliferation and invasion	8
YAP1‑mediated cytoplasmic‑nuclear translocation of SREBP2 promotes colorectal cancer via regulation of cholesterol metabolism	8
Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review)	8
S100 protein family: Emerging role and mechanism in digestive tract cancer (Review)	8
Cooperation between ZEB2 and SP1 upregulates PD‑L1 and CCL2 to promote the immunosuppressive activity of tumor cells	8
A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer	8
Adjusting for comorbidity in observational cancer studies: A systematic review to assess alignment between index and study	8
Research progress on the role of tumor‑associated macrophages in tumor development and their use as molecular targets (Review)	8
Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)	8
[Expression of Concern] Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin‑like growth factor 2 imprinting	8
[Retracted] Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples	8
Selective antitumor and apoptosis‑inducing effects of the Src inhibitor PP1 in human tongue squamous cell carcinoma cells	7
Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review)	7
Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review)	7
[Retracted] SRF‑miR‑29b‑MMP2 axis inhibits NSCLC invasion and metastasis	7
Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer	7
Beyond the membrane: Internalization and compartmentalization of insulin‑like growth factor 1 receptor signaling in cancer pathogenesis and treatment (Review)	7
Pancreatic cancer EMT‑targeted therapy: Molecular mechanisms and clinical translation (Review)	7
A perspective on the chemical structures and molecular mechanisms of curcumin and its derivatives and analogs in cancer treatment (Review)	7
Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR‑124/SIRT1 axis in cervical cancer cells	7
Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9	7
[Retracted] Silencing the long noncoding RNA, TINCR , a molecular sponge of miR‑335 , inhibits the maligna	7
[Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway	7
The role of deubiquitinating enzymes and their inhibitors in esophageal carcinoma (Review)	7
Targeting ferroptosis in Helicobacter pylori ‑associated gastric cancer development: From molecular mechanisms to application prospects (Review)	7
RNA‑binding protein DAZAP1 promotes gastric cancer metastasis by enhancing NOTCH1 and JAG1 mRNA stability	7
Current developments of pharmacotherapy targeting heme oxygenase 1 in cancer (Review)	7
Upregulation of the EGFR/MEK1/MAPK1/2 signaling axis as a mechanism of resistance to antiestrogen‑induced BimEL dependent apoptosis in ER⁺ breast cancer cells	7
Deubiquitinating enzymes in cervical cancer: Molecular mechanisms and therapeutic implications (Review)	7
Notch3 mediated TGF‑β1 activation enhances epithelial‑mesenchymal transition and cancer stemness in non‑small lung cancer	7
The important regulatory roles of circRNA‑encoded proteins or peptides in cancer pathogenesis (Review)	7
RNA binding proteins in extracellular vesicles and their potential value for cancer diagnosis and treatment (Review)	7
Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review)	7
Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization	7
Roles of m⁶A modification in oral cancer (Review)	7
Decoding long non‑coding RNAs: Friends and foes in cancer development (Review)	6
CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells	6
MicroRNA‑21: A potential therapeutic target in lung cancer (Review)	6
Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway	6
[Retracted] uPAR and cathepsin B knockdown inhibits radiation‑induced PKC integrated integrin signaling to the cytoskeleton of glioma‑initiating cells	6
[Expression of Concern] AHIF promotes glioblastoma progression and radioresistance via exosomes	6
Immunoediting and precision biomarkers in prostate cancer: The emerging role of liquid biopsy, immune contexture and HLA genotype (Review)	6
Harnessing TP73‑targeted nintedanib: A novel strategy to halt triple‑negative breast cancer via p53‑PPARα/PI3K‑Akt pathway suppression	6
Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)	6
N⁶‑methyladenosine‑induced long non‑coding RNA PVT1 regulates the miR‑27b‑3p/BLM axis to promote prostate cancer progression	6
Role of histone modifications in gastric cancer (Review)	6
Targeting neddylation as a novel approach to lung cancer treatment (Review)	6
Ovarian tumor deubiquitinase 6A regulates cell proliferation via deubiquitination of nucleolin and caspase‑7	6
Enolase 1: A paradigm of metabolic enzyme moonlighting in tumorigenesis (Review)	6
[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth	6
MEF2A is a transcription factor for circPVT1 and contributes to the malignancy of acute myeloid leukemia	6
DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells	6
A novel lncRNA 495810 promotes the aerobic glycolysis in colorectal cancer by stabilizing pyruvate kinase isozyme M2	6
[Retracted] Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma	6
HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer	6
Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review)	6
Downregulation of miR‑7 and miR‑153 is involved in Helicobacter pylori CagA induced gastric carcinogenesis and progression	5
Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc	5
Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR/PI3K/AKT pathway	5
Discovery of the late autophagy inhibitor FZU‑0045‑053 and its anti‑breast cancer and immunomodulatory effects	5
PD‑1/PD‑L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)	5
Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review)	5
Synergistic and toxicity‑reducing effects of acteoside as an adjuvant therapy of oxaliplatin against hepatocellular carcinoma	5
[Retracted] MicroRNA‑24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3	5
[Corrigendum] Furin promotes epithelial‑mesenchymal transition in pancreatic cancer cells via Hippo‑YAP pathway	5
Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA	5
Role and underlying mechanisms of miR‑200 family in breast cancer (Review)	5
Long non‑coding RNAs in multiple myeloma (Review)	5
Eupalinolide A induces autophagy via the ROS/ERK signaling pathway in hepatocellular carcinoma cells in vitro and in vivo	5
Progerin regulates actin cytoskeletal remodeling and inhibits EMT and metastasis in triple‑negative breast cancer cells	5
PPM1G and its diagnostic, prognostic and therapeutic potential in HCC (Review)	5
Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review)	5
Emerging roles of RNA m6A modification in multiple myeloma pathogenesis and treatment resistance (Review)	5